About Zevacor

Our vision is to impact patient lives by providing an optimal platform for the innovation of the next generation of imaging agents, which will improve diagnostic and therapeutic care, leading to better clinical outcomes.

Zevacor Molecular is a subsidiary of Illinois Health and Science (IHS), a non-profit healthcare system that specializes in enhancing patient care through strategic investments in healthcare-related opportunities.  Zevacor takes pride in helping fulfill IHS’s mission to enhance longevity and the quality of human life through improved patient care and outcomes. Zevacor Molecular develops, manufactures and distributes PET and SPECT radiopharmaceuticals used in nuclear medicine and molecular imaging. In addition, Zevacor Molecular has finalized the construction of a new 70 MeV cyclotron and multiple synthesis and processing units for production and distribution of a broad range of clinical and research radioisotopes at its Noblesville, IN headquarters and Zevacor Molecular also provides investigative and custom radiolabeling services to pharmaceutical, biotech, and research institutions nationwide helping them develop the next generation of molecular imaging and therapeutic products.